Uncommon Descent Serving The Intelligent Design Community
Category

rhetoric

agit-prop, opinion manipulation and well-poisoning games

L& FP41: Dawkins, Krauss and trying to pull a world out of “no-thing”

As Cardinal Pell has been recently cleared, perhaps some may be willing to learn from this telling vid: No, Virginia, you do not get a world from no-thing. END

L&FP40: Language is . . . (as a foundation for understanding machine code and mathematical language as just that, linguistic)

It seems we need to clarify language. For, we see in the Ortho types thread: EG, 140: >> . . . Definitions of language: Webster’s: the words, their pronunciation, and the methods of combining them used and understood by a community. Britannica: a system of conventional spoken, manual (signed), or written symbols by means of which human beings, as members of a social group and participants in its culture, express themselves. Cambridge: a system of communication consisting of sounds, words, and grammar, or the system of communication used by people in a particular country or type of work. Collins: A language is a system of communication which consists of a set of sounds and written symbols which are used by Read More ›

L&FP39: How the folded structure (and then the “loading”) of tRNA corrects attempts to reduce protein synthesis to “mere” chemistry

One of the more astonishing rhetorical gambits of objectors to the design inference is to try to suggest that the alphanumeric, code-using, algorithmic information system we see in the D/RNA of the living cell and linked protein synthesis is not really an information system, it all reduces to chemical reaction trains. A common associated gambit is to assert that terms like “code” etc are all readily dismissible analogies. As a first reminder, protein synthesis as graphically summarised: Of course, it never hurts to remind such objectors of p. 5 of Sir Francis Crick’s $6 million, March 19, 1953 letter to his son, Michael: Notice, his belief right from the outset of discovering the double-helix stricture: “. . . D.N.A. is Read More ›

A note on layer-cake communication systems and protocols

There is a live exchange on the molecular nanotech communication systems in the cell that is trying to reduce them to Chemistry; where a chemical reaction is a physical process. Accordingly, I beg to remind one and all regarding layered communication systems and protocols: This is an elaboration of the general communication system: Here is how Yockey summarised it: Where, the standard genetic code [one of about two dozen dialects] reads like: The double helix: As was noted by Crick, right from the outset: In context: Now, we can see for ourselves just how desperate objectors to the design inference must be in the face of the point that D/RNA expresses a string data structure carrying a prong-height-based alphanumeric, 4 Read More ›

OWID — Covid patterns

Let’s look at daily confirmed cases: and at a seven-day rolling average for deaths: South Korea seems to have beaten this wave. Several advanced countries show a stubborn plateau, which is reflected in the linear ongoing growth. It is not confined to the US, we need to learn from the Koreans; who BTW are HCQ users. The “mesa” for China underscores the observation that Chinese data has to be regarded with care. END

Azithromycin (HCQ’s sidekick) is apparently far more than an antibiotic

There is a report that Azithromycin is far more than an antibiotic. Some may wish to watch an interview with Dr. Michael Lisanti on antibiotics for COVID-19 and cancer. But — without endorsing as “proved” fact — let’s cut to the chase scene: COVID-19 coronavirus is particularly dangerous for the elderly or those with aging-related senescent illnesses like diabetes, cancer, heart disease, and lung disease. As Professor Lisanti said in a statement on his new paper in the journal Aging, “If you look at the host receptors of COVID-19, they are related to senescence. Two proteins have been proposed to be the cellular receptors of COVID-19: one is CD26 – a marker of senescence, and the other, ACE-2, is also Read More ›

A low-cost ventilator based on the Ambu Bag (do you think a “Gold Standard” Placebo control is needed . . . )

Ventilators are a key treatment for Covid-19, and there has been a wave of interest concerning development of low-cost ventilators; especially with a projected Covid-19 wave in excess of 100 millions for Africa. Here, then, is the Israel developed AmboVent, one of something like 300 fast-track initiatives to develop such globally: Video: This is of course one of several designs pivoting on the nearly ubiquitous manual respirator bulb, as per a suggestion that has been on the table for some time. Now we see a [near-?] commercial product. Video on the suggestion: Their blurb: The AmboVent initiative is led, by the Israeli Air Force (IAF) 108 electronic depot in partnership with Magen David Adom (MDA) (Israel’s red cross). The R&D Read More ›

UVA as an antiviral? — AYTU Healight (in partnership with Cedars-Sinai)

H’mm, it just may be feasible to use actinic radiation as a respiratory tract antiviral: Screenshot: U/D: From cache, another screen shot: Notice, AYTU is restricting bandwidth to UVA, UVA 400 nm – 320 nm, which is less damaging to us than shorter wavelength UV bands. Interesting concept, at minimum, though how they would get it deeper into the lungs is another question. Let’s not forget, radiation therapy — using X-Rays — is still used to destroy cancer. I guess, another use- it- early solution, if it works. END U/D, PS: I found a Fox News mention:

Dr Raoult in his own voice on HCQ, with English sub-titles

Jerry has again hit gold, and so here is Dr Didier Raoult, in his own voice, with English sub-titles: Let us view and discuss. U/D: it will be helpful to take time to follow this video also, where others have a say. (As time permits, I will put up some screen captures as updates below.) Let us view and let us think together. END F/N: Let me stack screen shots, first, who and what we are dealing with: Next, the study: Note, for reference, its approval: Research protocol approved by the ANSM [= “Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM)”, i.e. National Agency for the Safety of Medicines and Health Products] and the Île-de-France CPP Read More ›

Dr Zelenko’s HCQ-based ALT-ernative to the near-Business As Usual (n-BAU) approach

Jerry drew our attention last night to a radio interview by Dr Vladimir Zelenko. In this interview, he summarises his approach and rationale, giving results and making several announcements. (Unfortunately, the media cannot be embedded at UD as it is not YT. Kindly, go here; and make sure your browser has no active ad blocker.) On listening last night, here are my first observations on highlight points: Brazil and Israel are doing his early treatment, clinical diagnosis (backed up by nasal swab test), outpatient-oriented dosage for vulnerable patients protocol, ALT-1. He has treated 405 in that profile and sees 95% reduction on the expected death rate for the n-BAU baseline. He points out that the Raoult [by implication] protocol, which Read More ›

On Scientific Methods and alternatives to the “Placebo Control is the gold standard” view, in the face of pandemics (–> Logic & First Principles, 38)

It is clear that we need to re-think how we go about doing science to warrant approaches to the pandemic. So, allow me to headline a comment from the double-blind thread: KF, 16: >> I am also thinking back to the old “Scientific Method” summary we were taught in schools and its roots in Newton’s Opticks, Query 31: As in Mathematicks, so in Natural Philosophy, the Investigation of difficult Things by the Method of Analysis, ought ever to precede the Method of Composition. This Analysis consists in making Experiments and Observations, and in drawing general Conclusions from them by Induction, and admitting of no Objections against the Conclusions, but such as are taken from Experiments, or other certain Truths. For Read More ›

Guardian exemplifies the placebo control gold standard fallacy (–> being, Logic and First Principles, 37)

Shortly after I posted yesterday on whether placebo based studies are properly a gold standard, one of our common objectors, JT, linked the Guardian. Perhaps, he did not realise just how aptly it illustrates my point. I therefore responded, as I now headline as a shop window case- in- point illustration of what is going wrong with medical testing, linked statistics and linked ethics . . . not to mention, too much of the media and the way we tend to think: This is part of why I have written as I have in the OP: [Guardian, annotated:] >>The French doctor Didier Raoult has claimed [–> has reported, on now almost 3,000 patients, under a test protocol approved by relevant Read More ›

Are double-blind placebo-controlled studies the rightful “gold standard”? (So that, whatever does not “measure up” can be discounted or dismissed?)

As we have seen in recent weeks as Covid-19 and Hydrochloroquine cocktail treatments have been on the table, there is a clear tendency to view and treat double-blind placebo controlled testing as a “gold standard” yardstick and to then use such to discount and dismiss whatever does not “measure up” such as Professor Raoult’s work over in France. I will now argue in outline that such an attitude is selectively hyperskeptical, seriously ethically, epistemologically and logically flawed, and sets up a crooked yardstick. It is a commonplace in Medical research that arguably more lives were saved, net, than perished through the tainted medical studies in the Nazi death camps. However, the taint was seen as so serious that a programme Read More ›

Hydrochloroquine on the march, as this wave of Covid-19 peaks

Prof Raoult’s web site hosts an interesting map, under the title, “Pays où l’hydroxychloroquine est recommandée”: India, of course, has the further approval for prophylaxis. That’s significant, as talk on vaccines tends to point to 12 – 18 months and double-blind, placebo controlled tests in progress or about to start in the US look likely to take more than a year. Meanwhile, OWID tracks how time to double to current number of deaths — probably the best statistic — is continuing to stretch out: (Notice, the S-curves and driving impulses.) Likewise, we can see the daily cases clearly peaking (for THIS wave . . . notice, Wave 2 for China and even an uptick to a Wave 3): This is Read More ›

OWID on Case Fatality Rate to date vs median age of population

HT, BA77, here is a plot of CFR vs median age, with size of bubble keyed to number of fatalities: In this context, Prof Didier Raoult’s 1061 case study’s low fatality rate for elderly persons, 0.5% as reported, seems quite significant. Related, here is the Chinese CDC report on CFR by age: Then, we may note Raoult’s observed pattern for treatment: I trust these will be helpful. END